Harel Insurance Investments & Financial Services’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2
Closed 687
2023
Q3
$0 Buy
+2
New +$55 ﹤0.01% 773
2020
Q4
Sell
-1,300
Closed -$148K 785
2020
Q3
$148K Buy
+1,300
New +$137K 0.01% 345

Other funds holding TNDM

Harel Insurance Investments & Financial Services's TNDM Position: Q4 2023 in Review

Harel Insurance Investments & Financial Services sold out of Tandem Diabetes Care (TNDM) in Q4 2023, closing a stake of 2 shares.

Harel Insurance Investments & Financial Services first reported a position in TNDM in Q3 2020 and held it in 2 quarters. The position peaked at $148K in Q3 2020. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2023.

  • Harel Insurance Investments & Financial Services reported no remaining Tandem Diabetes Care position as of Q4 2023 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 2 Tandem Diabetes Care shares in Q4 2023.
  • Harel Insurance Investments & Financial Services first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 2 quarters.
  • Harel Insurance Investments & Financial Services's Tandem Diabetes Care position peaked at $148K in Q3 2020.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2023.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2023, filed 30 Jan 2024.